AINDEX
Markets

Nexentis Technologies Inc. (NXTS)

NXTSNASDAQ-CMAgricultural Chemicals

$2.52

+0.0150 (+0.60%) today

At the close, Nov 10, 4:00 PM ET. After hours $2.56 –

+0.60% 1D
Market cap
$7.58m
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
$2.36 to $2.75
52-week range
$2.14 to $119.00
Average volume
97.4k
Previous close
$2.51

Financials

QuarterJun 2025Sep 2025Mar 2026Jun 2026
Revenue–$68.0k––
Gross profit–$49.0k––
Operating income-$2.63m-$1.65m-$8.22m-$1.88m
Net income-$4.51m$429.0k-$6.58m-$11.14m

News

8 latest

The company

Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd. , a drug-discovery company. Additionally, Nexentis adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd. , a wholly owned subsidiary of Solterra Energy Ltd.

Sector
Industrials
Industry
Agricultural Chemicals
Exchange
NASDAQ-CM
Region
Middle East
Website
n2off.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.